Table 1.
Summary table
| Code number1 | Commodity | Existing EU MRL (mg/kg) | Existing CXL (mg/kg) | Outcome of the review | |
|---|---|---|---|---|---|
| MRL (mg/kg) | Comment | ||||
|
Enforcement residue definition (existing): lufenuronF Enforcement residue definition (proposed): lufenuron (any ratio of constituent isomers)F | |||||
| 110020 | Oranges | 1 | – | 0.01* | Recommendeda |
| 110030 | Lemons | 1 | – | 0.01* | Recommendeda |
| 110040 | Limes | 1 | – | 0.01* | Recommendeda |
| 110050 | Mandarins | 1 | – | 0.01* | Recommendeda |
| 130010 | Apples | 0.5 | – | 0.15 | Recommendeda |
| 130020 | Pears | 0.5 | – | 0.15 | Recommendeda |
| 130030 | Quinces | 0.2 | – | 0.15 | Recommendeda |
| 130040 | Medlar | 0.2 | – | 0.15 | Recommendeda |
| 130050 | Loquats/Japanese medlars | 0.2 | – | 0.15 | Recommendeda |
| 140010 | Apricots | 1 | – | 0.2 | Further consideration neededb |
| 140020 | Cherries (sweet) | 1 | – | 0.01* | Recommendeda |
| 140030 | Peaches | 1 | – | 0.2 | Further consideration neededb |
| 140040 | Plums | 1 | – | 0.01* | Recommendeda |
| 151010 | Table grapes | 1 | – | 0.01* | Recommendeda |
| 151020 | Wine grapes | 1 | – | 0.01* | Recommendeda |
| 152000 | Strawberries | 1 | – | 1 | Further consideration neededc |
| 161020 | Figs | 0.02* | – | 0.01* | Recommendeda |
| 161060 | Kaki/Japanese persimmons | 0.02* | – | 0.01* | Recommendeda |
| 162010 | Kiwi fruits | 0.02* | – | 0.01* | Recommendeda |
| 211000 | Potatoes | 0.05 | 0.01* | 0.01* | Recommendede |
| 231010 | Tomatoes | 0.5 | 0.4 | 0.4 | Recommendedh |
| 231020 | Sweet peppers/bell peppers | 1 | 0.8 | 0.8 | Recommendedh |
| 231030 | Aubergines/eggplants | 0.2 | – | 0.3 | Recommendeda |
| 232010 | Cucumbers | 0.2 | 0.09 | 0.15 | Recommendede |
| 232020 | Gherkins | 0.2 | – | 0.2 | Further consideration neededc |
| 232030 | Courgettes | 0.2 | – | 0.15 | Recommendeda |
| 233010 | Melons | 0.3 | 0.4 | 0.4 | Recommendede |
| 233020 | Pumpkins | 0.2 | – | 0.4 | Recommendeda |
| 233030 | Watermelons | 0.3 | – | 0.4 | Recommendeda |
| 251010 | Lamb's lettuces/corn salads | 0.02* | – | 0.02 | Further consideration neededc |
| 251020 | Lettuces | 0.5 | – | 0.5 | Further consideration neededc |
| 251030 | Escaroles/broad‐leaved endives | 0.02* | – | 0.02 | Further consideration neededc |
| 251040 | Cresses and other sprouts and shoots | 0.02* | – | 0.02 | Further consideration neededc |
| 251050 | Land cresses | 0.02* | – | 0.02 | Further consideration neededc |
| 251060 | Roman rocket/rucola | 0.02* | – | 0.02 | Further consideration neededc |
| 251070 | Red mustards | 0.02* | – | 0.02 | Further consideration neededc |
| 251080 | Baby leaf crops (including Brassica species) | 0.02* | – | 0.02 | Further consideration neededc |
| 401070 | Soya bean | 0.02* | 0.01* | 0.01* | Recommendedi |
| 1011010 | Swine muscle | 0.02* | 0.03 | 0.03 | Recommendedi |
| 1011020 | Swine fat tissue | 0.02* | 0.7 | 0.7 | Recommendedi |
| 1011030 | Swine liver | 0.02* | 0.04 | 0.04 | Further consideration neededg |
| 1011040 | Swine kidney | 0.02* | 0.04 | 0.04 | Further consideration neededg |
| 1012010 | Bovine muscle | 0.02* | 0.03 | 0.03 | Recommendedh |
| 1012020 | Bovine fat tissue | 0.02* | 0.7 | 0.7 | Recommendedh |
| 1012030 | Bovine liver | 0.02* | 0.04 | 0.04 | Further consideration neededf |
| 1012040 | Bovine kidney | 0.02* | 0.04 | 0.04 | Further consideration neededf |
| 1013010 | Sheep muscle | 0.02* | 0.03 | 0.03 | Recommendedi |
| 1013020 | Sheep fat tissue | 0.02* | 0.7 | 0.7 | Recommendedi |
| 1013030 | Sheep liver | 0.02* | 0.04 | 0.04 | Further consideration neededg |
| 1013040 | Sheep kidney | 0.02* | 0.04 | 0.04 | Further consideration neededg |
| 1014010 | Goat muscle | 0.02* | 0.03 | 0.03 | Recommendedi |
| 1014020 | Goat fat tissue | 0.02* | 0.7 | 0.7 | Recommendedi |
| 1014030 | Goat liver | 0.02* | 0.04 | 0.04 | Further consideration neededg |
| 1014040 | Goat kidney | 0.02* | 0.04 | 0.04 | Further consideration neededg |
| 1015010 | Equine muscle | 0.02* | 0.03 | 0.03 | Recommendedh |
| 1015020 | Equine fat tissue | 0.02* | 0.7 | 0.7 | Recommendedh |
| 1015030 | Equine liver | 0.02* | 0.04 | 0.04 | Further consideration neededf |
| 1015040 | Equine kidney | 0.02* | 0.04 | 0.04 | Further consideration neededf |
| 1016010 | Poultry muscle | 0.02* | 0.01* | 0.02* | Recommendedi |
| 1016020 | Poultry fat tissue | 0.02* | 0.04 | 0.04 | Recommendedi |
| 1016030 | Poultry liver | 0.02* | 0.02 | 0.02* | Further consideration neededg |
| 1020010 | Cattle milk | 0.02* | 0.1 | 0.1 | Recommendedi |
| 1020020 | Sheep milk | 0.02* | 0.1 | 0.1 | Recommendedi |
| 1020030 | Goat milk | 0.02* | 0.1 | 0.1 | Recommendedi |
| 1020040 | Horse milk | 0.02* | 0.1 | 0.1 | Recommendedi |
| 1030000 | Birds eggs | 0.02* | 0.02 | 0.02* | Recommendedi |
| – | Other commodities of plant and/or animal origin | See Reg. (EC) No 839/2008 | – | – | Further consideration neededd |
MRL: maximum residue level; CXL: codex maximum residue limit.
*Indicates that the MRL is set/proposed at the limit of quantification.
1 Commodity code number, as listed in Annex I of Regulation (EC) No 396/2005.
F Residue is fat soluble.
MRL is derived from a GAP evaluated at the EU level, which is fully supported by data and for which no risk to consumers is identified; no CXL is available (combination G‐I in Appendix D).
Tentative MRL is derived from a GAP evaluated at the EU level, which is not fully supported by data but for which no risk to consumers was identified; no CXL is available (combination E‐I in Appendix D).
GAP evaluated at the EU level is not supported by data but no risk to consumers was identified for the existing EU MRL; no CXL is available (combination C‐I in Appendix D).
There are no relevant authorisations or import tolerances reported at the EU level; no CXL is available. Either a specific LOQ or the default MRL of 0.01 mg/kg may be considered (combination A‐I in Appendix D).
MRL is derived from a GAP evaluated at the EU level, which is fully supported by data and for which no risk to consumers is identified; existing CXL is covered by the recommended MRL (combination G‐III in Appendix D).
MRL is derived from the existing CXL, which is not sufficiently supported by data but for which no risk to consumers is identified; GAP evaluated at the EU level, which is also not fully supported by data, would lead to a lower tentative MRL (combination E‐V in Appendix D).
MRL is derived from the existing CXL, which is not sufficiently supported by data but for which no risk to consumers is identified; there are no relevant authorisations or import tolerances reported at the EU level (combination A‐V in Appendix D).
MRL is derived from the existing CXL, which is supported by data and for which no risk to consumers is identified; GAP evaluated at the EU level, which is also fully supported by data, leads to a lower MRL (combination G‐VII in Appendix D).
MRL is derived from the existing CXL, which is supported by data and for which no risk to consumers is identified; there are no relevant authorisations or import tolerances reported at the EU level (combination A‐VII in Appendix D).